AlzChem Group AG

XTRA:ACT 주식 보고서

시가총액: €582.1m

AlzChem Group 미래 성장

Future 기준 확인 3/6

AlzChem Group (는) 각각 연간 12.6% 및 7.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 12.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 24% 로 예상됩니다.

주요 정보

12.6%

수익 성장률

12.6%

EPS 성장률

Chemicals 수익 성장35.1%
매출 성장률7.5%
향후 자기자본 수익률24.0%
애널리스트 커버리지

Low

마지막 업데이트11 Nov 2024

최근 미래 성장 업데이트

Recent updates

AlzChem Group's (ETR:ACT) Earnings May Just Be The Starting Point

Nov 14
AlzChem Group's (ETR:ACT) Earnings May Just Be The Starting Point

AlzChem Group AG's (ETR:ACT) Shares Leap 26% Yet They're Still Not Telling The Full Story

Oct 27
AlzChem Group AG's (ETR:ACT) Shares Leap 26% Yet They're Still Not Telling The Full Story

When Should You Buy AlzChem Group AG (ETR:ACT)?

Oct 18
When Should You Buy AlzChem Group AG (ETR:ACT)?

AlzChem Group (ETR:ACT) Has A Pretty Healthy Balance Sheet

Sep 07
AlzChem Group (ETR:ACT) Has A Pretty Healthy Balance Sheet

A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)

Jun 04
A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)

AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising

May 08
AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising

Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

May 01
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 26
AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Is AlzChem Group (ETR:ACT) A Risky Investment?

Apr 11
Is AlzChem Group (ETR:ACT) A Risky Investment?

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Mar 07
The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Nov 01
Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

Oct 12
Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

May 06
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

May 05
AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

Apr 05
AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

Mar 04
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

Apr 24
AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

Feb 27
AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 23
AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

Jun 10
Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

Apr 07
At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

Mar 23
AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 10
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 24
Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Feb 11
Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

수익 및 매출 성장 예측

XTRA:ACT - 애널리스트의 미래 추정치 및 과거 재무 데이터 (EUR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202663661481084
12/31/202559655331344
12/31/20245665251924
9/30/20245645082103N/A
6/30/2024555467697N/A
3/31/2024546397396N/A
12/31/2023546355273N/A
9/30/2023533302555N/A
6/30/2023554282453N/A
3/31/202357030-1512N/A
12/31/202255030-33-4N/A
9/30/202253429-254N/A
6/30/202248728-280N/A
3/31/202245427329N/A
12/31/2021429281443N/A
9/30/2021420271140N/A
6/30/2021406263463N/A
3/31/2021397231448N/A
12/31/2020386202049N/A
9/30/2020370161052N/A
6/30/2020389171153N/A
3/31/2020387172054N/A
12/31/201938518244N/A
9/30/201938919242N/A
6/30/201938018-1822N/A
3/31/201938020-2033N/A
12/31/201838323-535N/A
9/30/2018380221224N/A
6/30/201839832N/A31N/A
3/31/201836421N/A23N/A
12/31/201736120N/A31N/A
9/30/201735622N/A31N/A
12/31/201633315N/A33N/A
9/30/201633112N/A39N/A
12/31/201532915N/A30N/A
12/31/201429814N/A18N/A
12/31/201330217N/A16N/A

애널리스트 미래 성장 예측

수입 대 저축률: ACT 의 연간 예상 수익 증가율( 12.6% )이 saving rate( 1% 보다 높습니다. ).

수익 vs 시장: ACT 의 연간 수익( 12.6% ) German 시장( 20.8% 보다 느리게 성장할 것으로 예상됩니다. 20.8% 연간).

고성장 수익: ACT 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: ACT 의 수익(연간 7.5% ) German 시장( 5.6% 보다 빠르게 성장할 것으로 예상됩니다. 5.6% 연간).

고성장 수익: ACT 의 수익(연간 7.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ACT 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 24 %)

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y